Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Orion Resource Report Resource Website 10+ mentions |
Orion (RRID:SCR_003911) | Orion | commercial organization | A globally operating Finnish developer, manufacturer and marketer of human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. They are continuously developing new drugs and treatment methods. Pharmaceutical RD focuses on central nervous system drugs, oncology and critical care drugs, and Easyhaler pulmonary drugs. | pharmaceutical, drug, diagnostic test, diagnostic, central nervous system, drug, oncology, critical care, pulmonary, central nervous system drug, pulmonary drug, cancer, veterinary drug, medicine, clinical, hygiene monitoring |
is related to: MIP-DILI is related to: NEWMEDS is related to: ORBITO is related to: PREDECT |
Cancer, Asthma, Alzheimer's disease, Parkinson's disease, Breast cancer, Prostate cancer | nlx_158257 | SCR_003911 | Orion Corporation, Orion Pharma | 2026-08-15 11:22:44 | 34 | |||||||
|
Genentech Resource Report Resource Website 1000+ mentions |
Genentech (RRID:SCR_003997) | Genentech | commercial organization | A biotechnology corporation that uses human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious or life-threatening medical conditions. | drug, genetic, medicine, biotechnology, oncology, immunology, tissue growth, tissue repair, neuroscience, infectious disease, microbiology, medical imaging |
is related to: Alzheimers Disease Genetics Consortium has parent organization: Roche is parent organization of: GMAP |
Infectious disease, Cancer | nlx_158417 | SCR_003997 | Genentech Inc, F. Hoffmann-La Roche Ltd / Genentech | 2026-08-15 11:22:43 | 3311 | |||||||
|
ACTTION Resource Report Resource Website 1+ mentions |
ACTTION (RRID:SCR_004003) | ACTTiON | organization portal, data or information resource, consortium, portal | A public-private partnership with the United States Food and Drug Administration (FDA) to identify, prioritize, sponsor, coordinate, and promote innovative activities - with a special interest in optimizing clinical trials - that will expedite the discovery and development of improved analgesic, anesthetic, and addiction medications and to more generally accelerate the development of treatments with improved efficacy and safety. This multi-year, multi-phase initiative is closely aligned with the FDA''''s Critical Path Initiative. The key objectives of ACTTION involve initiating and supporting strategic collaborations among a broad spectrum of stakeholders - including, but not limited to, academia, the FDA and other government agencies, industry, professional organizations, patient advocacy groups, foundations, and philanthropic organizations - with the goals of sharing data and innovative thinking about the development of novel therapeutics. These strategic collaborations involve a wide range of research projects and other activities, for example, scientific workshops, consensus meetings, and in-depth analyses of clinical trial data to determine the effects of research methods on study assay sensitivity and efficiency. ACTTION launched an initiative to develop training materials for clinical trial subjects (and staff) to be used with pain rating scales and other pain-related patient reported outcomes. Once materials have been developed and evaluated, proof-of-concept trials will be conducted to test the hypothesis that patient and staff training can improve the assay sensitivity of analgesic trials. | drug, analgesic, anesthetic, clinical trial, drug development, product development, data sharing, pain rating scale, patient reported outcome, training material, medicine |
is listed by: Consortia-pedia is related to: Critical Path Initiative has parent organization: University of Rochester; New York; USA has parent organization: University of Washington; Seattle; USA |
FDA | nlx_158414 | SCR_004003 | Analgesic Anesthetic and Addiction Clinical Trial Translations Innovations Opportunities and Networks, AAACTTiON | 2026-08-15 11:22:47 | 8 | |||||||
|
SciBite Resource Report Resource Website 1+ mentions |
SciBite (RRID:SCR_003952) | SciBite | commercial organization | An informatics service focusing on competitor intelligence and text-mining within the life sciences. It mines a diverse array of scientific content to look for mentions of targets, indications, companies, drugs and technologies of interest to those involved in human health and drug discovery. A free newsletter service is provided to allow everyone to explore the therapeutic landscape and stay informed and a range of professional products and services are offered for those who need more in-depth analysis of the therapeutic landscape. Its text-mining engine can be configured to a variety of different use cases and performs with very high throughput. SciBite has a number of big-pharma and scientific publishers as current customers. SciBITES is free on the website but for extended functionality, including a data mining API and access to internal or commercial documents, you may wish to consider an installation of the SciBITES server software within your organization. | text-mining, biomedical, drug discovery, pharmaceutical, data mining, biotechnology, drug, newsletter, semantics, ontology, termite, text-mining software | is related to: Open PHACTS | Free, Subscription, API access, License | nlx_158349 | SCR_003952 | SciBite Limited | 2026-08-15 11:22:45 | 2 | |||||||
|
EnCor Biotechnology Inc. Resource Report Resource Website 1+ mentions |
EnCor Biotechnology Inc. (RRID:SCR_003951) | commercial organization | Company committed to development, characterization and manufacture of antibody and ELISA type assays for academic, biopharmaceutical and clinical research. | Company, antibody, ELISA, assay, reagent | is related to: University of Florida; Florida; USA | Commercially available | nlx_152355 | SCR_003951 | 2026-08-15 11:22:42 | 5 | |||||||||
|
Alzheimers Disease Genetics Consortium Resource Report Resource Website 10+ mentions |
Alzheimers Disease Genetics Consortium (RRID:SCR_004004) | ADGC | portal, data or information resource, data set, consortium, organization portal | Consortium to conduct genome-wide association studies (GWAS) to identify genes associated with an increased risk of developing late-onset Alzheimer''''s disease (LOAD). The goal of the ADGC is to identify genetic variants associated with risk for AD. It plans to do this through the following collaborative goals: # Identify genes responsible for AD susceptibility # Identify AD sub-phenotype genes rate-of-progression plaque / tangle load / distribution biomarker variability # Generate a genetic data resource for the AD research community Data generated by ADGC is available at the following website: https://www.niagads.org/content/alzheimers-disease-genetics-consortium-adgc-collection | genome-wide association study, gene, biomarker, basic science, genetic variant, genetics, african-american, caucasian |
is listed by: Consortia-pedia is related to: University of Pennsylvania Perelman School of Medicine; Pennsylvania; USA is related to: Icahn School of Medicine at Mount Sinai; New York; USA is related to: University of Washington; Seattle; USA is related to: Boston University; Massachusetts; USA is related to: Washington University in St. Louis; Missouri; USA is related to: Vanderbilt University; Tennessee; USA is related to: Oregon Health and Science University; Oregon; USA is related to: Columbia University; New York; USA is related to: University of Miami; Florida; USA is related to: Banner Alzheimer's Institute; Arizona; USA is related to: Indiana University; Indiana; USA is related to: University of Toronto; Ontario; Canada is related to: Mayo Clinic Florida; Florida; USA is related to: Johns Hopkins University; Maryland; USA is related to: Albert Einstein College of Medicine; New York; USA is related to: Genentech is related to: University of Gothenburg; Gothenburg; Sweden is related to: University of North Texas; Texas; USA is related to: University of Kentucky; Kentucky; USA is related to: University of Chicago; Illinois; USA is related to: University of Michigan; Ann Arbor; USA is related to: University of Virginia; Virginia; USA is related to: Florida Alzheimer's Disease Research Center is related to: Mayo Clinic is related to: Emory University; Georgia; USA is related to: New York University; New York; USA is related to: Stanford University; Stanford; California is related to: Northwestern University Feinberg School of Medicine; Illinois; USA is related to: University of Alabama; Alabama; USA is related to: University of Arkansas for Medical Sciences; Arkansas; USA is related to: University of San Diego; California; USA is related to: University of California at Irvine; California; USA is related to: University of California at Los Angeles; California; USA is related to: University of California at San Diego; California; USA is related to: University of California at San Francisco; California; USA is related to: University of Pittsburgh; Pennsylvania; USA is related to: University of Southern California; Los Angeles; USA is related to: University of Texas Southwestern Medical Center; Texas; USA is related to: National Alzheimer's Coordinating Center is related to: Childrens Hospital of Philadelphia - Research Institute; Pennsylvania; USA is related to: National Institute on Aging is related to: University of California at Davis; California; USA is related to: Mayo Clinic College of Medicine is related to: Wake Forest University; North Carolina; USA is related to: National Cell Repository for Alzheimer's Disease is related to: International Genomics of Alzheimers Project is related to: National Alzheimer's Coordinating Center has parent organization: University of Pennsylvania Perelman School of Medicine; Pennsylvania; USA |
NIA UO1AG032984 | nlx_158415 | SCR_004004 | Alzheimer''''s Disease Genetics Consortium (ADGC), Alzheimer''''s Disease Genetics Consortium | 2026-08-15 11:22:40 | 12 | |||||||
|
Simcyp Resource Report Resource Website 100+ mentions |
Simcyp (RRID:SCR_003944) | commercial organization | Research based company providing predictive pharmacokinetic and pharmacodynamic tools, workshops and consultancy services. Their user-friendly simulator and databases predict drug absorption, clearance, distribution and metabolic drug-drug interactions from in vitro data. Simcyp's clients include major global pharmaceutical and bioscience companies, leading academic institutes and regulatory authorities. These clients form the Simcyp Consortium, which together with independent International Scientific Advisory Board, guide scientific development at Simcyp.Simcyp was acquired by Certara in 2012. | modelling, simulation, pharmaceutical, drug development, pharmacokinetics, pharmacodynamics, population, drug-drug interaction, clinical, infant, child, adult, drug, interaction, database, FASEB list |
is related to: ORBITO is related to: Certara |
European Union FP6 ; UK Department of Trade and Industry |
nlx_158337 | SCR_003944 | Simcyp Ltd, Simcyp Limited | 2026-08-15 11:22:38 | 177 | ||||||||
|
BioSolveIT Resource Report Resource Website 100+ mentions |
BioSolveIT (RRID:SCR_003949) | BioSolveIT | commercial organization | Commercial provider of software solutions for drug discovery applications offering tools, services, and research collaborations. The software portfolio ranges from design, over screening, to the visualization of ligand libraries, for hit identification, optimization, and scaffold hopping. With a stellar scientific advisory board and founders from academia who intensely collaborate with pharma, BioSolveIT catalyzes products off of university research successes with proven pharmaceutical industry application. They provide software products within the areas of ligand and structure-based drug design and is the pioneer of computational fragment-based ligand design. BioSolveIT innovate break-throughs in drug discovery by supplying smooth, user-centered designed tools bringing different researchers together for efficient multidisciplinary drug design. | drug discovery, drug, ligand, structure, drug design | is related to: Open PHACTS | Free for academic use, License required | nlx_158346 | SCR_003949 | BioSolveIT GmbH | 2026-08-15 11:22:45 | 126 | |||||||
|
ESTEVE Resource Report Resource Website 1+ mentions |
ESTEVE (RRID:SCR_003948) | commercial organization | A pharmaceutical chemical group in Spain with a presence worldwide. It operates in the pharmaceutical sector by researching and developing new drugs, marketing a wide range of ethical and OTC products, generics, vaccines and also products for hospital and veterinary use. Through its subsidiary Esteve Qu??mica is also present in the Active Pharmaceutical Ingredients sector. | pharmaceutical, chemical, drug, medicine, veterinary, vaccine, over-the-counter drug, generic drug | is related to: Open PHACTS | nlx_158341 | http://www.esteve.com | SCR_003948 | Laboratorios del Dr. Esteve S.A. | 2026-08-15 11:22:42 | 3 | ||||||||
|
bioRxiv Resource Report Resource Website 1000+ mentions |
bioRxiv (RRID:SCR_003933) | bioRxiv | community building portal, data or information resource, database, portal | A free archive and distribution service for unpublished preprints in the life sciences allowing authors to make their findings immediately available to the scientific community and receive feedback on draft manuscripts before they are submitted to journals. An article may be posted prior to, or concurrently with, submission to a journal but should not be posted if it has already been published. Once an article is published in a journal, bioRxiv will update the preprint with a link to the published version. | preprint, life science, bio.tools, FASEB list |
is used by: PrePubMed is listed by: LabWorm is listed by: bio.tools is listed by: Debian is related to: Overleaf has parent organization: Cold Spring Harbor Laboratory |
Free, Acknowledgement requested, The community can contribute to this resource | nlx_158302, biotools:bioRxiv | https://bio.tools/bioRxiv | SCR_003933 | bioRxiv - the preprint server for biology | 2026-08-15 11:22:38 | 1368 | ||||||
|
Git Resource Report Resource Website 50+ mentions |
Git (RRID:SCR_003932) | software application, software resource, software development tool, version source control system | A free and open source distributed version control system designed to handle everything from small to very large projects with speed and efficiency. Git is easy to learn and has a tiny footprint with lightning fast performance. It outclasses SCM tools like Subversion, CVS, Perforce, and ClearCase with features like cheap local branching, convenient staging areas, and multiple workflows. | version control, distributed, bio.tools |
is used by: DataLad is used by: G-Node Data Infrastructure Services is listed by: bio.tools is listed by: Debian works with: git-annex |
GNU General Public License, v2 | nlx_158301, biotools:Git | https://bio.tools/Git | SCR_003932 | 2026-08-15 11:22:45 | 73 | ||||||||
|
ALTA Resource Report Resource Website 10+ mentions |
ALTA (RRID:SCR_003898) | ALTA | commercial organization | A service-provider company specialized in developing and managing scientific research projects. Its mission is to support research activities from the idea to the realization of project. ALTA assists in finding the proper strategy, building European Consortia and putting science in the most appropriate administrative and management framework. | manage | is related to: ONE Study | nlx_158231, grid.424010.3 | https://ror.org/04qd5p107 | SCR_003898 | ALTA Srlu, ALTA s.r.l.u. | 2026-08-15 11:22:38 | 32 | |||||||
|
Eisai Resource Report Resource Website 10+ mentions |
Eisai (RRID:SCR_003936) | Eisai | commercial organization | A global pharmaceutical company. | pharmaceutical, healthcare, drug, oncology, central nervous system, neurology, medicine | is related to: PharmaCog | Cancer, Epilepsy, Alzheimer's disease, Obesity, Immune-mediated disease, Insomnia | grid.418767.b, Wikidata: Q29123933, nlx_158312, ISNI: 0000 0004 0599 8842 | https://ror.org/0469x1750 | SCR_003936 | Eisai Co. Ltd., EISAI Ltd | 2026-08-15 11:22:38 | 17 | ||||||
|
Sartorius Resource Report Resource Website 100+ mentions |
Sartorius (RRID:SCR_003935) | SSB | commercial organization | Commercial organization that provides laboratory and process technologies and equipment. Their products and services help customers around the globe implement complex and quality-critical processes in biopharmaceutical production and laboratory environments in a time- and cost-efficient way. Sartorius operates its own production facilities in Europe, Asia and America, and also has sales offices and local representatives in more than 110 countries. | laboratory, process technology, equipment, biopharmaceutical |
is related to: Thermo Fisher: Sartorius: Ambr 15 Cell Culture Generation 2 is related to: Pharma-Planta Consortium provides: IncuCyte® Chemotaxis Software |
nlx_158308 | SCR_003935 | Sartorius-Stedim Biotech, Sartorius AG, Sartorius Stedim Biotech S.A., Sartorius Stedim Biotech | 2026-08-15 11:22:45 | 119 | ||||||||
|
Baxter Resource Report Resource Website 50+ mentions |
Baxter (RRID:SCR_003974) | BAX | commercial organization | A global healthcare company with expertise in medical devices, pharmaceuticals and biotechnology. Through its subsidiaries, they develop, manufacture and market products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. BioScience Baxter is a manufacturer of recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products; and vaccines. Baxter''s Medical Products business manufactures products used in the delivery of fluids and drugs to patients. These include intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, IV nutrition products, infusion pumps and inhalation anesthetics. The business also provides products and services related to pharmacy compounding, drug formulation and packaging technologies. In addition, Baxter''s Medical Products business is a leader in Renal home-based therapies, such as peritoneal dialysis, and offers other products and services for people with end-stage kidney disease. | health care, medical equipment, bioscience, medical product, medical device, pharmaceutical, biotechnology | is related to: Kidney Health Initiative | Hemophilia, Kidney disease, Immune disorder, Chronic medical condition, Acute medical condition, Infectious disease, Trauma, Bleeding disorder | Wikidata: Q43895073, grid.487322.8, nlx_158381, ISNI: 0000 0000 9098 0655 | https://ror.org/01mgtdr23 | SCR_003974 | Baxter International Inc., Baxter International | 2026-08-15 11:22:39 | 51 | ||||||
|
Association for the Advancement of Medical Instrumentation Resource Report Resource Website 1+ mentions |
Association for the Advancement of Medical Instrumentation (RRID:SCR_003973) | AAMI | nonprofit organization | A nonprofit organization made up of a diverse community of healthcare technology professionals that support the healthcare community in the development, management, and use of safe and effective medical technology. It is the primary source of consensus and timely information on medical instrumentation and technology. * AAMI is the primary resource for the industry, the professions, and government for national and international standards. * AAMI provides multidisciplinary leadership and programs that enhance the ability of the professions, healthcare institutions, and industry to understand, develop, manage, and use medical instrumentation and related technologies safely and effectively. * AAMI helps members: contain costs, keep informed of new technology and policy developments, add value in healthcare organizations, and improve professional skills and enhance patient care. * AAMI provides a unique and critical forum for members who cover a complete range of interests, from clinical and biomedical engineers and technicians, physicians, nurses, and hospital administrators, to educators and researchers, manufacturers, distributors, government representatives and other healthcare professionals with an interest in medical devices. * AAMI fulfills its mission through: ** continuing education, conferences ** certification of healthcare technical specialists ** the publication of technical documents, periodicals, books, software. | safety, efficacy, medical instrument, medical device, clinical, training resource, patient care, medical technology | is related to: Kidney Health Initiative | ISNI: 0000 0000 8633 8985, nlx_158380, grid.489418.8, Wikidata: Q4809544 | https://ror.org/023vxq234 | SCR_003973 | 2026-08-15 11:22:46 | 1 | ||||||||
|
American Society of Diagnostic and Interventional Nephrology Resource Report Resource Website 1+ mentions |
American Society of Diagnostic and Interventional Nephrology (RRID:SCR_003968) | ASDIN | community building portal, data or information resource, training resource, portal | Society that aims to promote the proper application of new and existing procedures to improve the care of patients with kidney disease. They promote education, research, public policy and clinical practice initiatives relating to diagnostic and interventional procedures. ASDIN works closely with other societies and programs to achieve its goals. All professionals involved in the care of patients with kidney disease are welcome to join and become active in the Society. Activities of the Society include: * the establishment of practice standards, * certification of physicians in specific procedures, * accreditation of training programs in specific procedures, * development of training tools and techniques, * sponsoring symposia and training courses, * and the dissemination of information through periodic meetings and through print and other media. | nephrology, diagnostic, intervention, clinical, kidney | is related to: Kidney Health Initiative | Kidney disease | nlx_158373 | SCR_003968 | American Society of Diagnostic & Interventional Nephrology | 2026-08-15 11:22:39 | 3 | |||||||
|
KaLy-Cell Resource Report Resource Website 10+ mentions |
KaLy-Cell (RRID:SCR_003963) | KaLy-Cell | commercial organization | Commercial organization that offers human and animal hepatocyte products as well as other products derived from liver tissue, kits and media. Services they offer include in vitro metabolism, in vitro toxicology and cell therapy. | hepatocyte, in vitro, metabolism, toxicology, cell therapy, liver tissue, liver, cell culture, drug metabolism, drug transporter, enzyme induction, enzyme inhibition, drug, metabolism, transporter, enzyme, induction, inhibition, culture |
is listed by: One Mind Biospecimen Bank Listing is related to: MIP-DILI |
nlx_158365 | SCR_003963 | 2026-08-15 11:22:42 | 14 | |||||||||
|
Centers for Medicare and Medicaid Services Resource Report Resource Website 10+ mentions |
Centers for Medicare and Medicaid Services (RRID:SCR_003962) | CMS | government granting agency | is parent organization of: Kidney Health Initiative | SCR_003962 | CMS.gov, Centers for Medicare & Medicaid Services | 2026-08-15 11:22:39 | 11 | |||||||||||
|
Cellartis Resource Report Resource Website 10+ mentions |
Cellartis (RRID:SCR_003960) | Cellartis | commercial organization | THIS RESOURCE IS OUT OF SERVICE, documented on July 23, 2021. Company focusing on stem cell derived products and services for drug discovery, toxicity testing and applications within regenerative medicine. The company leverages long-standing experience in stem cell handling and scale up together with leading expertise in differentiation of cells into mature and functional human cells. The laboratories are prepared to meet the EU and US guidelines for current Good Manufacturing Practice (cGMP). Now part of Takara Bio Inc. | Stem cell derived products and services, drug discovery, toxicity testing, applications within regenerative medicine |
is listed by: One Mind Biospecimen Bank Listing is related to: MIP-DILI is related to: Takara Bio Inc. |
nlx_158362 | SCR_003960 | Cellectis AB, Cellartis AB, Takara Bio Inc. | 2026-08-15 11:22:42 | 33 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.